Purchase Order 75F40124P00365
Award Date 8/13/24
Potential Completion Date 8/13/29
Potential Value $486K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Reston, VA 20190, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a direct 8(a) sole source, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for professional services to support the FDA's Oncology Center of Excellence, with an ultimate completion date of August 11, 2026 and a ceiling value of $2,220,109.12. Aneon Brillient, LLC specializes in providing a variety of professional services to the FDA,...
- The Food and Drug Administration awarded a definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for shipping, receiving, printing support, and administrative support services to the Office of Regulatory Affairs Office of Training, Education, and Development on September 17, 2024, under an 8(a) sole-source set-aside with a ceiling value of $409,085.88. Work is performed in Reston, Virginia, under a labor-hours pricing structure. The contract extends through March...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract is for $164,005.68 to provide communications support services for the Immediate Office of the FDA Commissioner, with a period of performance through July 13, 2026. Aneon Brillient, LLC is a limited liability company based in Reston, Virginia that specializes in providing...
- <p>The Food and Drug Administration awarded a $144,540.21 labor-hour definitive contract to Aneon Brillient, LLC for additive manufacturing of medical products core facility support on May 23, 2024, under an 8(a) sole-source set-aside.</p> <p>Aneon Brillient, LLC is an SBA-certified 8(a) joint venture, minority-owned small disadvantaged business. Place of performance is Silver Spring, MD. The contract ceiling is $144,540.21 with an ultimate completion date of June 30, 2026.</p>
- <p>The Food and Drug Administration (FDA) awarded a 1-year, firm fixed price type contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture, to provide program support staff for the FDA's Office of Global Policy and Strategy. This is a direct 8(a) sole source award with a ceiling value of $152,077.08. The contract will be performed in Calverton, Maryland and has a completion date of June 12, 2025.</p>
- The Food and Drug Administration awarded a $2,366,901 definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for communication, administrative, and information disclosure support services to the Center for Devices and Radiological Health on August 26, 2024, under an 8(a) sole-source set-aside. The contract is a three-year labor-hour engagement with an ultimate completion date of August 26, 2027. Place of performance is Reston, VA. A modification (P00003) revised Option...
- The U.S. Food and Drug Administration (FDA) awarded a $122,611.14 task order to Brillient Corporation, a minority-owned digital transformation company, under a Professional and Technical Services Blanket Purchase Agreement. The award, made on July 12, 2023, is designated as a Competitive 8(a) set-aside and is scheduled for completion by May 25, 2026. Work will be performed in Reston, Virginia, with pricing structured on a time and materials basis. The task order supports the FDA's Center for...
- The Food and Drug Administration awarded a definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for Freedom of Information Act support services to the FDA's Center for Biologics Evaluation and Research on August 26, 2024, under a direct 8(a) sole-source award with a ceiling value of $1,155,825.04. Place of performance is Silver Spring, Maryland. The labor-hour contract structure covers FOIA support services for CBER operations. The ultimate completion date is...
- This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to Brillient Corporation, a minority-owned small business. The contract, valued at $139,863.45, is for administrative support services and is a call order under the FDA's Professional and Technical Services Blanket Purchase Agreement (BPA). The contract has an ultimate completion date of August 26, 2024. Brillient Corporation is an experienced federal contractor, having been awarded numerous...
- This is a labor hour award from the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA) to Brillient Corporation, a Minority Owned Business, for science database administration support services. The contract was awarded under the Professional and Technical Services Blanket Purchase Agreement on the Professional Services Schedule (PSS) of the General Services Administration (GSA). The contract has a potential value of $194,765.86 and runs through May...